Last week’s top stocks that were bought by their CEOs were Msci Inc-A, Winmark, and Biostante Pharma. According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Msci Inc-A (NYSE:MSCI): Chairman, CEO and President Henry A Fernandez Bought 6,255 Shares
Chairman, CEO and President of Msci Inc-A (NYSE:MSCI) Henry A Fernandez bought 6,255 shares on 01/19/2011 at an average price of $35.5. MSCI Inc. is a provider of investment decision support tools to investment institutions worldwide. Msci Inc-a has a market cap of $4.18 billion; its shares were traded at around $35.5 with a P/E ratio of 28.6 and P/S ratio of 9.5.
MSCI recently reported its fourth quarter results. Net income increased by 23.4% to $30.3 million in fourth quarter 2010. For fiscal year 2010, net income increased by 12.7% to $92.2 million. Diluted EPS for fourth quarter 2010 rose 4.2% to $0.25. For fiscal year 2010, Diluted EPS rose 1.3% to $0.81.
Ron Baron owns 10,810,690 shares as of 09/30/2010, which accounts for 2.37% of the $15.15 billion portfolio of Baron Funds. Chuck Akre owns 150,000 shares as of 09/30/2010, which accounts for 1.26% of the $395 million portfolio of Akre Capital Management, LLC. George Soros owns 28,225 shares as of 09/30/2010, which accounts for 0.01% of the $6.69 billion portfolio of Soros Fund Management LLC.
Sell: CFO David M Obstler sold 25,000 shares of MSCI stock on 10/19/2010 at the average price of 36.35. David M Obstler owns at least 14,520 shares after this. The price of the stock has decreased by 2.34% since. There are mixed trades from other insiders.
Winmark Corp (NASDAQ:WINA): Chairman & CEO, 10% Owner John L Morgan Bought 3,600 Shares
Chairman & CEO, 10% Owner of Winmark Corp (NASDAQ:WINA) John L Morgan bought 3,600 shares on 01/18/2011 at an average price of $33. Winmark Corporation is a franchise company that franchises seven retail concepts which buy, sell, trade and consign merchandise. Winmark Corp has a market cap of $162 million; its shares were traded at around $33 with a P/E ratio of 19.6 and P/S ratio of 4.4. The dividend yield of Winmark Corp stocks is 0.2%. Winmark Corp had an annual average earning growth of 9.4% over the past 10 years.
WINA recently announced net income for the quarter ended September 25, 2010 of $2,690,000, or $.51 per share diluted, compared to net income of $1,779,500, or $.33 per share diluted, in 2009. For the nine months ended September 25, 2010, net income was $7,209,800, or $1.39 per share diluted, compared to net income of $4,388,500, or $.82 per share diluted, for the same period last year.
Buy: President of Franchising Steven Murphy bought 600 shares of WINA stock on 01/06/2011 at the average price of 33.5. Steven Murphy owns at least 27,802 shares after this. The price of the stock has decreased by 1.49% since. There are mixed trades from other insiders.
Biosante Pharma (BPAX): Vice Chairman, President & CEO Stephen M Simes Bought 5,000 Shares
Vice Chairman, President & CEO of Biosante Pharma (BPAX) Stephen M Simes bought 5,000 shares on 01/18/2011 at an average price of $1.85. Biosante Pharmaceutical is an emerging pharmaceutical company developing a pipeline of hormone therapy products to treat both men and women. Biosante Pharma has a market cap of $127.9 million; its shares were traded at around $1.85 with and P/S ratio of 101.6.
BPAX recently reported its third quarter 2010 results. BioSante incurred a net loss of approximately $11.6 million or ($0.16) per share for the quarter ended September 30, 2010, compared to a net loss of $6.4 million or ($0.21) per share for the same period in 2009. This increase in net loss was primarily due to increased LibiGel clinical development expenses.
Buy: Sr. VP of Finance, CFO & Sec'y Philip B Donenberg bought 1,000 shares of BPAX stock on 01/21/2011 at the average price of 1.88. Philip B Donenberg owns at least 42,322 shares after this. The price of the stock has decreased by 1.6% since. Other insiders have also increased their positions in the company.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.